Business ❯Finance ❯Investment ❯Stock Market

Pharmaceutical Stocks

Novo Nordisk Faces Investor Turmoil as Wegovy Sales and Market Share Decline

Johnson & Johnson to Acquire Intra-Cellular Therapies in $14.6 Billion Deal